Spain - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Spain Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry jumped by 5.3% year on year. In 2019, the country was ranked number 9 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry at $1,127,374,718.22 Million PPP. Spain is overtaken by Denmark, which was number 8 with $1,510,421,981.56 Million PPP and is followed by France with $1,080,008,891 Million PPP. United States topped the ranking with $70,565,318,932.39 Million PPP in 2019, a growth of 3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania witnessed the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 1,127,374,718.22 |
| 2018 | 1,098,593,500.43 |
| 2017 | 1,107,391,305.22 |
| 2016 | 982,299,468.72 |
| 2015 | 892,818,503.00 |
How does Spain rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 8 |
#8
Denmark
|
1,510,421,981.56 | 2019 | +2.8 % | +5.4 % | View data | |
| 9 |
#9
Spain
|
1,127,374,718.22 | 2019 | +2.6 % | +5.3 % | View data | |
| 10 |
#10
France
|
1,080,008,891.00 | 2019 | -0.1 % | +0.4 % | View data | |